Workflow
兆龙互连: 关于2022年限制性股票激励计划首次授予部分第三个归属期及预留授予部分第二个归属期归属条件成就的公告

Core Viewpoint - The company has announced the achievement of vesting conditions for the third vesting period of the initial grant and the second vesting period of the reserved grant under the 2022 Restricted Stock Incentive Plan, allowing a total of 126 individuals to receive shares [1][2][21]. Summary by Sections Incentive Plan Overview - The 2022 Restricted Stock Incentive Plan was approved on July 4, 2022, with a total grant of 2.6 million shares, representing 1.41% of the company's total share capital at the time [2][3]. - The initial grant consisted of 2.25 million shares, with a grant price of 7.64 yuan per share [3][4]. Vesting Conditions and Achievements - For the initial grant's third vesting period, 82 individuals are eligible to receive 1.016668 million shares, while 47 individuals in the reserved grant's second vesting period are eligible for 219,912 shares [2][19]. - The adjusted vesting price is set at 4.28 yuan per share [1][19]. Performance Assessment - The performance assessment for the vesting conditions includes company-level and individual-level evaluations, with specific revenue and net profit growth targets set for the years 2022 to 2024 [5][6][18]. - The company achieved a net profit of approximately 162 million yuan for 2024, reflecting an 83.58% increase compared to 2021, thus meeting the performance criteria for the vesting conditions [18]. Adjustments and Cancellations - Adjustments to the grant price and number of shares have been made over time, with the initial grant price adjusted from 7.64 yuan to 4.28 yuan [15][24]. - A total of 93,140 shares were canceled due to individuals no longer qualifying as incentive recipients [15][23]. Compliance and Approval - The board and supervisory committee have confirmed that the vesting conditions have been met and that the incentive plan complies with relevant laws and regulations [21][23][25]. - The company will continue to fulfill its disclosure obligations as required by law [24][26].